ストックスクリーナーアプリを入手
33.86
0.65%
0.22
アフターアワーズ：
33.42
-0.44
-1.30%
前日終値:
$33.64
開ける：
$33.76
24時間の取引高:
2.78M
Relative Volume:
0.73
時価総額：
$14.73B
収益：
$2.27B
当期純損益:
$1.15B
株価収益率:
13.28
EPS:
2.55
ネットキャッシュフロー:
$2.80B
1週間 パフォーマンス:
+0.18%
1か月 パフォーマンス:
+8.08%
6か月 パフォーマンス:
+17.24%
1年 パフォーマンス:
+13.13%
1日の値動き範囲:
$33.69
$34.10
1週間の範囲:
$32.92
$34.12
52週間の値動き範囲:
$24.05
$34.20
Royalty Pharma Plc Stock (RPRX) Company Profile
名前
Royalty Pharma Plc
セクター
電話
(212) 883-0200
住所
110 EAST 59TH STREET, NEW YORK, NY
RPRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
33.86 | 14.73B | 2.27B | 1.15B | 2.80B | 2.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-03 | ダウングレード | UBS | Buy → Neutral |
| 2022-06-14 | 再開されました | UBS | Buy |
| 2022-05-13 | 開始されました | Scotiabank | Sector Outperform |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2022-04-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 再開されました | Morgan Stanley | Overweight |
| 2021-10-29 | アップグレード | Citigroup | Neutral → Buy |
| 2021-07-30 | 開始されました | Tigress Financial | Buy |
| 2020-11-09 | アップグレード | UBS | Neutral → Buy |
| 2020-07-14 | 開始されました | Evercore ISI | In-line |
| 2020-07-13 | 開始されました | BofA Securities | Buy |
| 2020-07-13 | 開始されました | Citigroup | Neutral |
| 2020-07-13 | 開始されました | Cowen | Outperform |
| 2020-07-13 | 開始されました | Goldman | Neutral |
| 2020-07-13 | 開始されました | JP Morgan | Neutral |
| 2020-07-13 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 開始されました | SunTrust | Buy |
| 2020-07-13 | 開始されました | UBS | Neutral |
すべてを表示
Royalty Pharma Plc (RPRX) 最新ニュース
Marathon Asset Management Ltd Sells 46,981 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
53,542 Shares in Royalty Pharma plc (NASDAQ:RPRX) Acquired by SBI Securities Co. Ltd. - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Los Angeles Capital Management LLC Sells 346,803 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Has $3.23 Million Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Holdings Boosted by Illinois Municipal Retirement Fund - MarketBeat
New York State Common Retirement Fund Has $6.81 Million Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Reaches New 12-Month HighHere's What Happened - MarketBeat
Royalty Pharma to Present at TD Cowen's 45th Annual Health Care Conference - The Manila Times
What Will Royalty Pharma Reveal at TD Cowen's Healthcare Conference Next Week? - StockTitan
Royalty Pharma plcOrdinary SharesClass A to Host Earnings Call - ACCESS Newswire
8,998 Shares in Royalty Pharma plc (NASDAQ:RPRX) Purchased by Vontobel Holding Ltd. - MarketBeat
ING Groep NV Invests $2.92 Million in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Handelsbanken Fonder AB Has $11.74 Million Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma stock hits 52-week high at $33.71 amid growth - Investing.com Australia
Peering Into Royalty Pharma's Recent Short Interest - Benzinga
Bryn Mawr Capital Management LLC Purchases 47,964 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Sets New 1-Year HighHere's Why - MarketBeat
Why Royalty Pharma Plc (RPRX) is the Best Performing Pharma Stock So Far in 2025 - Insider Monkey
10 Best Performing Pharma Stocks So Far in 2025 - Insider Monkey
Allspring Global Investments Holdings LLC Boosts Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Baillie Gifford & Co. Sells 1,987,975 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Van ECK Associates Corp Increases Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Ex-Dividend Reminder: Royalty Pharma, Piedmont Office Realty Trust and Western Asset Diversified Income - Nasdaq
2 Hot Growth Stocks Poised for Gains of Up to 370%, According to Wall Street - The Globe and Mail
(RPRX) Trading Signals - Stock Traders Daily
Royalty Pharma (RPRX) to Release Quarterly Earnings on Thursday - MarketBeat
Sumitomo Mitsui Trust Group Inc. Reduces Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
abrdn plc Sells 14,685 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Issues Quarterly Earnings Results, Beats Estimates By $0.16 EPS - MarketBeat
Royalty Pharma’s Internalization Strategy: Navigating Risks and Uncertainties Ahead of 2025 Transition - MSN
Royalty Pharma (NASDAQ:RPRX) Sets New 12-Month High After Better-Than-Expected Earnings - MarketBeat
Royalty Pharma's Strong Portfolio Growth and Manager Acquisition Boost Long-Term Outlook - Morningstar
Royalty Pharma targets $3B share buyback and projects 4-9% growth in 2025 portfolio receipts - MSN
Royalty Pharma Plc (RPRX) 財務データ
収益
当期純利益
現金流量
EPS
1.23%
7.54%
大文字化:
|
ボリューム (24 時間):